skip to Main Content
Get your free newsletter: Actionable insight each morning for self-directed investors. 

Three things you need to know in the financial markets this morning from investment writer, Tony Cross.

Aquis Exchange

Aquis Exchange [LON:AQX] has published its interim results this morning, covering the period to June 30th. Revenues jumped by 42% to almost £5 million, with the company moving into profit as a result. The market share of all European trading also grew from 3.56% to 4.51%. The venue has interesting ambitions which include the prohibiting of short selling, something which could well help attract more new issuers over time.


Waste management firm Biffa [LON:BIFF] has issued a trading update today. Business has remained slightly above the base case set out at the start of the pandemic, with August revenues having recovered to 90% and the company expects to cease is furlough scheme this month. On the basis consumption generates more waste, the company’s near term fortunes are tied to the shape of the economic recovery, Current expectations remain unchanged.


Synairgen [LON:SNG] has issued an IP update this morning. Following yesterday’s successful Phase II trial announcement in COPD patients, the company has submitted a patent application to cover treatment for this cohort. The note adds that whilst this is a positive development, the focus remains on use of the SNG001 therapy when treating COVID-19. Whether this is sufficient to offer shares another boost is something likely worth watching.

Sign up for three quick facts and more with our Free Daily Digest newsletter, every weekday morning.

Become a better investor with SharePad Designed to give you the confidence to pick your own investments, Sharepad gives you access to a wealth of information on UK, US & European stocks. Find out more

Please note this article does not constitute investment advice. Investors are encouraged to do their own research beforehand or consult a professional advisor.

Tony Cross

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we are following most closely. They all represent significant growth stories in our view. Our in-depth reports go into more detail on why we like them.


Get your free daily newsletter: 

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
Trade Nation
Back To Top